Nonspecific warm hemolysins of papain-treated cells: serologic characterization and transfusion risk.
D000371:Agglutination; D000818:Animals; D000906:Antibodies; D000888:Antibodies, Anti-Idiotypic; D001323:Autoantibodies; D001793:Blood Preservation; D001803:Blood Transfusion; D001963:Bromelains / Q000494:pharmacology; D003165:Complement System Proteins; D003298:Coombs Test; D004492:Edetic Acid / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology; D005260:Female; D006168:Guinea Pigs; D006460:Hemolysin Proteins; D006461:Hemolysis; D006801:Humans; D008297:Male; D009439:Neuraminidase / Q000494:pharmacology; D010206:Papain / Q000494:pharmacology*; D013696:Temperature; D013997:Time Factors; D065227:Transfusion Reaction; D014357:Trypsin / Q000494:pharmacology
D000906:Antibodies; D000888:Antibodies, Anti-Idiotypic; D001323:Autoantibodies; D006460:Hemolysin Proteins; D001963:Bromelains; D003165:Complement System Proteins; D004492:Edetic Acid; D009439:Neuraminidase; D014357:Trypsin; D010206:Papain